As of 2025-01-25, the Relative Valuation of TG Therapeutics Inc (TGTX) is (0.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.26 USD, the upside of TG Therapeutics Inc based on Relative Valuation is -100.3%.
The range of the Relative Valuation is (1.67) - 3.15 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 35.0x | 26.6x |
| Forward P/E multiples | 20.3x - 46.3x | 33.3x |
| Fair Price | (1.67) - 3.15 | (0.09) |
| Upside | -105.3% - -89.9% | -100.3% |
| Date | P/E |
| 2025-01-24 | -338.78 |
| 2025-01-23 | -314.72 |
| 2025-01-22 | -315.81 |
| 2025-01-21 | -323.61 |
| 2025-01-17 | -320.25 |
| 2025-01-16 | -315.81 |
| 2025-01-15 | -327.08 |
| 2025-01-14 | -322.31 |
| 2025-01-13 | -299.87 |
| 2025-01-10 | -312.99 |
| 2025-01-08 | -311.80 |
| 2025-01-07 | -303.45 |
| 2025-01-06 | -303.45 |
| 2025-01-03 | -325.67 |
| 2025-01-02 | -336.61 |
| 2024-12-31 | -326.21 |
| 2024-12-30 | -340.79 |
| 2024-12-27 | -352.54 |
| 2024-12-26 | -363.06 |
| 2024-12-24 | -348.53 |
| 2024-12-23 | -349.62 |
| 2024-12-20 | -348.97 |
| 2024-12-19 | -335.42 |
| 2024-12-18 | -336.67 |
| 2024-12-17 | -363.82 |
| 2024-12-16 | -372.81 |
| 2024-12-13 | -347.02 |
| 2024-12-12 | -332.60 |
| 2024-12-11 | -343.01 |
| 2024-12-10 | -343.22 |
| 2024-12-09 | -355.90 |
| 2024-12-06 | -367.72 |
| 2024-12-05 | -364.68 |
| 2024-12-04 | -367.17 |
| 2024-12-03 | -361.86 |
| 2024-12-02 | -380.29 |
| 2024-11-29 | -377.15 |
| 2024-11-27 | -379.31 |
| 2024-11-26 | -371.29 |
| 2024-11-25 | -375.09 |
| 2024-11-22 | -380.07 |
| 2024-11-21 | -374.44 |
| 2024-11-20 | -337.59 |
| 2024-11-19 | -328.59 |
| 2024-11-18 | -320.90 |
| 2024-11-15 | -320.14 |
| 2024-11-14 | -334.28 |
| 2024-11-13 | -378.23 |
| 2024-11-12 | -334.99 |
| 2024-11-11 | -333.15 |